Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mizgerd JP: Acute lower respiratory tract infection. N Engl J Med. 2008, 358: 716-727. 10.1056/NEJMra074111.
Falade AG, Ayede AI: Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries–a review. Afr J Med Med Sci. 2011, 40: 293-308.
Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR: The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010, 126: 256-262. 10.1016/j.jaci.2010.05.026.
Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM: Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol. 2011, 187: 3145-3154. 10.4049/jimmunol.1100764.
Villena J, Oliveira ML, Ferreira PC, Salva S, Alvarez S: Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol. 2011, 11: 1633-1645. 10.1016/j.intimp.2011.06.004.
Salva S, Villena J, Alvarez S: Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. International Journal of Food Microbiology. 2010, 141: 82-89. 10.1016/j.ijfoodmicro.2010.03.013.
Salva S, Nunez M, Villena J, Ramon A, Font G, Alvarez S: Development of a fermented goats' milk containing Lactobacillus rhamnosus: in vivo study of health benefits. J Sci Food Agric. 2011, 91: 2355-2362. 10.1002/jsfa.4467.
Villena J, Racedo S, Aguero G, Bru E, Medina M, Alvarez S: Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr. 2005, 135: 1462-1469.
Kiyono H, Fukuyama S: NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol. 2004, 4: 699-710. 10.1038/nri1439.
Medina M, Villena J, Salva S, Vintini E, Langella P, Alvarez S: Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol Immunol. 2008, 52: 399-409. 10.1111/j.1348-0421.2008.00050.x.
Villena J, Barbieri N, Salva S, Herrera M, Alvarez S: Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiol Immunol. 2009, 53: 636-646. 10.1111/j.1348-0421.2009.00171.x.
Villena J, Chiba E, Tomosada Y, Salva S, Marranzino G, Kitazawa H, Alvarez S: Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C). BMC Immunol. 2012, 13: 53-10.1186/1471-2172-13-53.
Londhe VA, Belperio JA, Keane MP, Burdick MD, Xue YY, Strieter RM: CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection. J Inflamm (Lond). 2005, 2: 4-10.1186/1476-9255-2-4.
Stowell NC, Seideman J, Raymond HA, Smalley KA, Lamb RJ, Egenolf DD, Bugelski PJ, Murray LA, Marsters PA, Bunting RA: Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir Res. 2009, 10: 43-10.1186/1465-9921-10-43.
Hori T, Kiyoshima J, Shida K, Yasui H: Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol. 2001, 8: 593-597.
Gabryszewski SJ, Bachar O, Dyer KD, Percopo CM, Killoran KE, Domachowske JB, Rosenberg HF: Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol. 2011, 186: 1151-1161. 10.4049/jimmunol.1001751.
Barbieri N, Villena J, Herrera M, Salva S, Alvarez S: Nasally administered Lactobacillus rhamnosus accelerate the recovery of humoral immunity in B lymphocyte-deficient malnourished mice. J Nutr. 2013, 143: 227-235. 10.3945/jn.112.165811.
Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW: Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol. 2009, 83: 1492-1500. 10.1128/JVI.00671-08.
Hori T, Kiyoshima J, Shida K, Yasui H: Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol. 2002, 9: 105-108.
Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP: Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol. 2004, 31: 358-364. 10.1165/rcmb.2003-0388OC.
Furuhashi K, Suda T, Hasegawa H, Suzuki Y, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shibata K: Mouse lung CD103+ and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses. Am J Respir Cell Mol Biol. 2012, 46: 165-172. 10.1165/rcmb.2011-0070OC.
Yoda K, Miyazawa K, Harata G, He F: Immunobiotics and antiviral immunity. Immunobiotics and Immunogenics. Edited by: Kitazawa H, Villena J, Alvarez S. 2013, Enfield, New Hampshire, USA: Science Publishers CRC Press Taylor & Francis Group
Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, Yausi H: Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol. 2010, 50: 597-602. 10.1111/j.1472-765X.2010.02844.x.
Li F, Zhu H, Sun R, Wei H, Tian Z: Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol. 2012, 86: 2251-2258. 10.1128/JVI.06209-11.
Bem RA, Domachowske JB, Rosenberg HF: Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol. 2011, 301: L148-L156. 10.1152/ajplung.00065.2011.
Rutigliano JA, Graham BS: Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol. 2004, 173: 3408-3417.
Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney NP, Schuijs M, O'Garra A, Johansson C, Openshaw PJ: IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One. 2012, 7: e32371-10.1371/journal.pone.0032371.
McNamara PS, Smyth RL: The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull. 2002, 61: 13-28. 10.1093/bmb/61.1.13.
Collins PL, Melero JA: Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011, 162: 80-99. 10.1016/j.virusres.2011.09.020.
Graham BS, Johnson TR, Peebles RS: Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology. 2000, 48: 237-247. 10.1016/S0162-3109(00)00233-2.
Moore ML, Newcomb DC, Parekh VV, Van Kaer L, Collins RD, Zhou W, Goleniewska K, Chi MH, Mitchell D, Boyce JA: STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. J Immunol. 2009, 183: 2016-2026. 10.4049/jimmunol.0803167.
Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN: Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol. 2010, 3: 291-300. 10.1038/mi.2010.6.